|
| |
Transkaryotic Therapies Pages on BioPortfolio:
BioPortfolio - Transkaryotic Therapies Incorporated RKT
Transkaryotic Therapies Incorporated RKT - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/10324-Transkaryotic...
|
BioPortfolio - Hemophilia A
Founded in 1988, Transkaryotic Therapies, Inc. (TKT) is a leading biopharmaceutical company in the production and delivery of protein therapies.
...
http://www.bioportfolio.com/indepth/Hemophilia_A.html...
|
The Board of International Biotechnology Trust Plc (“IBT”) today ...
... Pfizer announced the acquisition of Vicuron, which still has to complete, and Shire has acquired Transkaryotic Therapies, Inc.. ...
http://www.bioportfolio.com/news/International_Biotechnology...
|
BioPortfolio - directory at genzyme
Transkaryotic Therapies - (Fabrazyme®) Represented Genzyme in asserting infringement of patent claims related to recombinant enzymes for treating . ...
http://www.bioportfolio.com/search/directory_at_genzyme.html...
|
BTECH REGULATORY RADAR - Tracking the Movement of Key Products ...
Transkaryotic Therapies' (NASDAQ: TKTX) iduronate-2-sulfatase (I2S) enzyme replacement therapy for the treatment of Hunter syndrome, has been ...
http://www.bioportfolio.com/news/btech_010702_3.htm...
|
BIOPHARMA EPO rDNA Amgen
Transkaryotic Therapies, Inc. (TKT) - Patent dispute. Aventis Pharma AG - Patent dispute. University of Chicago - R&D; Tech. ...
http://www.bioportfolio.com/BioPharma/BIOPHARMA_EPO_rDNA_Amg...
|
Biotech Tracker News - Upcoming FDA Endocrinologic and Metabolic ...
... and will consider Transkaryotic’s (NASDAQ: TKTX) Replagal the next day. Both enzyme replacement therapies are designed to treat Fabry disease, ...
http://www.bioportfolio.com/news/biotracker_7.htm...
|
LTKfarma announces its creation and names advisory board
6 Jul 2006 ... former General Counsel of Transkaryotic Therapeutics and former ... TK54 is a cell therapy product made up of modified T-cells, ...
http://www.bioportfolio.com/biotech_news/LTKfarma_1.htm...
|
Biotechnology News Transkaryotic Therapies Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - Shire - Profile
Department of Preclinical Discovery, Shire Human Genetic Therapies,- Cytometry B Clin Cytom. 2008 .... 7094400- Transkaryotic implantation ...
http://www.bioportfolio.com/biocorporate/31108-Shire.pdf...
|
Results from other life science and pharmaceutical sites:
Shire
On July 28, 2005 Shire acquired Transkaryotic Therapies, Inc. ... TKT believes Transkaryotic Therapy is well-suited to allow safe and long-term delivery of ...
http://www.shire.com/shire/Pipeline/technology/genetherapy.j...
|
BioSpace - Transkaryotic Therapies, Inc. News, Search Jobs, Events
Tamara L. Joseph Named General Counsel Of Transkaryotic Therapies, Inc. (TKT) ( TKTX) 10/19/2005 5:12:44 PM More... Transkaryotic Therapies, Inc. (TKT) ...
http://www.biospace.com/company_profile.aspx?CompanyID=1548...
|
Shire
Shire focuses its business on attention deficit and hyperactivity disorder, human genetic therapies and gastrointestinal diseases. ...
http://www.shire.com/...
|
Transkaryotic Therapies, Inc.
08:29 ET, Transkaryotic Therapies Awarded Transgenic Patent. Feb 10, 00. 16:29 ET, TKT Reports Year-End 1999 Financial Results. Jan 11, 00 ...
http://www.prnewswire.com/gh/cnoc/comp/120657.html...
|
BioPortfolio - Transkaryotic Therapies Incorporated RKT
Transkaryotic Therapies Incorporated RKT - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/10324-Transkaryotic...
|
Biotech, Clinical Research, Pharmaceutical News & Jobs
Biotech, clinical research, and pharmaceutical news and jobs as well as industry -renowned Career Fairs in various life science Hotbeds across the US.
http://www.biospace.com/Default.aspx...
|
Transkaryotic Therapies, Inc. Company Profile - Yahoo! Finance
Capsule info for Transkaryotic Therapies, Inc. ... Transkaryotic Therapies (TKT) has found its niche in niche drugs. Targeting rare diseases, it develops ...
http://biz.yahoo.com/ic/52/52232.html...
|
Corporate and Chancery
Transkaryotic Therapies, Inc. (“tkt”) with and into ... In re Appraisal of Transkaryotic Therapies, Inc.: Delaware Court of ...
http://www.fr.com/news/DCCsummary_FINAL.pdf...
|
TKT Retakes Factor VIII Gene Therapy Rights from Wyeth TKT Intends ...
11 /PRNewswire-FirstCall/ -- Transkaryotic Therapies, Inc. (Nasdaq: TKTX) today announced that it has retaken from Wyeth Pharmaceuticals (formerly Genetics ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Shire: Events Calendar
Shire to acquire Transkaryotic Therapies Inc. (TKT) for $1.6 Billion. Matthew Emmens, Chief Executive Officer, Angus Russell, Chief Financial Officer ...
http://www.shire.com/shire/InvestorRelations/showevent.jsp?t...
|
|
